Chapter 11 Trustee Appointed for ATG, Inc.Business Editors HAYWARD, Calif.--(BUSINESS WIRE)--Feb. 15, 2002 ATG ATG antithymocyte globulin. lymphocyte immune globulin (antithymocyte globulin equine, ATG, ATG equine, LIG) Atgam Pharmacologic class: Immunoglobulin Therapeutic class: Immunosuppressant , Inc. (Nasdaq:ATGC ATGC Adenine,Thymine, Guanine, & Cytosine ATGC Asiantaeth Trwyddedu Hywyr A Cherbydau (Welsh: Driver and Vehicle Licensing Agency, UK) ), a leading provider of low-level radioactive and low-level mixed waste treatment services, today announced the appointment of Robert I. Hanfling as Chapter 11 Trustee for ATG, Inc., the resignation of ATG's current management and termination of ATG's board of directors. On February 11, 2002, the Bankruptcy Court bankruptcy court n. the specialized Federal court in which bankruptcy matters under the Federal Bankruptcy Act are conducted. There are several bankruptcy courts in each state, and each one's territory covers several counties. for the Northern District of California approved the appointment of Robert I. Hanfling as the Chapter 11 Trustee for ATG, which filed for protection and reorganization under Chapter 11 of Title 11 of the United States Code Title 11 of the United States Code outlines the role of Bankruptcy in the United States Code.
LLC - Logical Link Control , bankruptcy counsel for Mr. Hanfling. "The waste processing facilities that the company operated are safely secured. The facilities are under a strict stabilization program and the waste is safeguarded," said Hanfling. In connection with Hanfling's appointment as trustee, the current management of ATG, including Doreen Chui, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , and Frank Chui, CFO See Chief Financial Officer. , has resigned effective February 13, 2002. About ATG ATG Inc. is a radioactive and hazardous waste Hazardous waste Any solid, liquid, or gaseous waste materials that, if improperly managed or disposed of, may pose substantial hazards to human health and the environment. Every industrial country in the world has had problems with managing hazardous wastes. management company that offers comprehensive thermal and non-thermal treatment solutions for low-level radioactive and low-level mixed waste generated by commercial, institutional and government clients such as nuclear power plants, medical facilities, research institutions and the U.S. Departments of Defense and Energy. This news release may contain forward-looking statements pursuant to the "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements involve risks and uncertainties, including, without limitation, the Company's new products and services, ability to attract and retain key managers, competition and various factors set forth under "Factors Affecting Future Operating Results" in the Company's annual report on Form 10-K and such other risks detailed from time to time in the Company's other reports filed with the Securities and Exchange Commission. Neither the Company or the Trustee undertake any obligation to publicly release the result of any revisions to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion